Breast Reconstruction Market to Grow with Revenue of $684.53 Million in 2025 profiling Top Industry Players - Mentor Worldwide, Sientra, GC Aesthetics, POLYTECH Health & Aesthetics, Hansbiomed, Ideal Implant, Guangzhou Wanhe Plastic Materials

The emergence of breast reconstruction is a substantial development in the field of medical research. We have a team of research specialists who will work with you to identify precisely the research you need and ensure its prompt delivery, reducing your risk.

Global Breast Reconstruction Market analyses the factors driving market along with those that act as restraints to its growth. The global breast reconstruction market is witnessing a sheer rise in the current scenario and is expected to expand in the coming years owing to various technological advancements made by the players operating in the market. However, stringent regulatory framework in the market is expected to hinder the market growth.

The global breast reconstruction market is expected to reach US$ 684.53 Mn in 2025 from US$ 526.47 Mn in 2017. The market is estimated to grow with a CAGR of 3.5% from 2018-2025, owing to factors such as rising prevalence of breast cancer, increase in number of regulatory approvals & new product launches, and growing number of breast reconstruction procedures.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPHE100001298?utm_source=OpenPR&utm_medium=Simran

The List of Companies
1. Allergan Plc
2. Mentor Worldwide LLC
3. Sientra Inc.
4. GC Aesthetics PLC
5. POLYTECH Health & Aesthetics GmbH
6. Hansbiomed Co. Ltd.
7. Ideal Implant Incorporated
8. Guangzhou Wanhe Plastic Materials Co., Ltd.
9. Establishment Labs S.A.
10. Groupe Sebbin SAS

The Asia Pacific is the largest geographic market and it is expected to be the largest revenue generator during the forecast period. The Asia Pacific breast reconstruction market is expected to grow with CAGR of 3.9% to US$ 132.3 Mn in 2025 from US$ 98.2 Mn in 2017. Factors such as, presence of a large pool of breast cancer patients and increasing awareness of breast reconstruction procedures, are likely to grow the market in the forecast period.

Post-Surgical Complications:
Although breast reconstruction does not possess any risk of breast cancer recurrence, a large number of post-operative complications are associated with it. These complications include occurrence of a mass or lump within the reconstructed breast due to the accumulation of clear fluid, pooling of blood near the reconstructed breast, infections, extrusion of the implant, blood clots, implant rupture, obesity, formation of hard scar tissue around the implant, diabetes etc. In addition, the breast implants also can cause a possible risk of developing anaplastic large cell lymphoma (ALCL) which refers to a rare form of immune system cancer.

For instance, the U.S. FDA as of September 2017 received 414 medical devices reports (MDRs) on Breast Implants associated Anaplastic Large Cell Lymphoma (BIA-ALCL). The risk of breast reconstruction failure increases even more after radiation therapy. For instance, according to a review article published by PRMA Plastic Surgery, about 1 in 3 implant breast reconstruction procedures fail after radiation therapy among breast cancer patients. Moreover, the implants also cause various complications if not removed or replaced at appropriate time. In case of autologous reconstruction, necrosis of the transferred tissues may cause serious medical complications. Thus, the aforementioned factors are expected to hamper the growth of breast reconstruction market at certain extent.

Development of Innovative Breast Reconstruction Products:
Patients undergoing unilateral or bilateral mastectomy procedures usually opt for breast reconstruction for various reasons that are inclusive of regaining the original shape of the breasts, improve aesthetic appeal and others. Thus, it is important for the market players to come up with innovative products that will boost the adoption of this procedure at marginal rates

Buy this Report at https://www.theinsightpartners.com/buy/TIPHE100001298?utm_source=OpenPR&utm_medium=Simran

Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

This release was published on openPR.